NCT06667375

Brief Summary

This study evaluates the extubation success and compares the survival rate in patients with signs of Covid-19 intubated with Masi, a novel type of mechanical ventilator, or with other conventional ventilators admitted in the ICU of a reference hospital in Lima, Peru between January and August 2021. The Masi mechanical ventilator works by automating a resuscitation bag with promising preclinical results. The key features of Masi are its low manufacturing cost, low dependence on a supply of high volumes of oxygen, low oxygen consumption, flexibility between non-invasive and invasive ventilation, and extended range of working environmental altitudes compared to commercially available ventilators. A retrospective study of variables and outcomes was done. The main goal of this study is to compare the survival rate of respiratory failure patients supported either with Masi or conventional ventilators at Hospital Vitarte II in Lima between January and August 2021.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 19, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 27, 2021

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2022

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

October 28, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 31, 2024

Completed
Last Updated

October 31, 2024

Status Verified

October 1, 2024

Enrollment Period

7 months

First QC Date

October 28, 2024

Last Update Submit

October 30, 2024

Conditions

Keywords

VentilatorsMedical devices,Data analysisTechnological innovation

Outcome Measures

Primary Outcomes (1)

  • ICU discharge status

    After being in the ventilator in the ICU what happened at extubation or censoring time.

    Patients were followed 15 days (median)

Secondary Outcomes (5)

  • Ventilator parameter: Oxygen Saturation (%)

    Patients were followed up 15 days (median)

  • Ventilator parameter: Respiratory rate (breaths/minute)

    Patients were followed up 15 days (median)

  • Ventilator parameter: PaO2/FiO2 ratio

    Patients were followed up 15 days (median)

  • Ventilator parameters: Tidal volumen (mL)

    Patients were followed up 15 days (median)

  • Ventilator parameters: PIP (mmHg)

    Patients were followed up 15 days (median)

Study Arms (2)

Masi

Patients who were diagnosed with Covid-19, with signs of Acute Respiratory Distress Syndrome (ARDS), intubated, and connected to an automated-bag mechanical ventilator in the ICU

Conventional

Patients who were diagnosed with Covid-19, with signs of Acute Respiratory Distress Syndrome (ARDS), intubated, and connected to a commercial mechanical ventilator in the ICU

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Data from patients that were diagnosed with Covid-19, intubated and connected to a mechanical ventilator in the ICU between January 19, 2021 to August 27, 2021 which coincides with the second Peruvian wave of the Covid-19 pandemics in the Hospital Vitarte II in Lima

You may qualify if:

  • Patients hospitalized to ICU requiring mechanical ventilation during COVID-19 pandemic
  • Over 18 years old

You may not qualify if:

  • \- None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pontificia Universidad Católica del Perú

Lima, 15023, Peru

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Fanny L Casado Peña, PhD

    Pontificia Universidad Catolica del Peru

    PRINCIPAL INVESTIGATOR
  • Sergio Sánchez-Gambetta, MD, MSc

    Pontificia Universidad Catolica del Peru

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

October 28, 2024

First Posted

October 31, 2024

Study Start

January 19, 2021

Primary Completion

August 27, 2021

Study Completion

December 20, 2022

Last Updated

October 31, 2024

Record last verified: 2024-10

Locations